Will "Commute-Home ETFs" Be Excluded from the Exchange's After-Hours Market Next Month?
Korea Exchange After-Market Set to Open Next Month
Exclusion of Exchange-Traded Products (ETPs) from Trading Appears Likely
The Impact of Factors Such as Single-Stock Leverage That Have Increased Market Volatility
[Edaily Reporter Kwon Oh Seok ] It has been decided that trading in exchange-traded products (ETPs) will be excluded from the Korea Exchange’s after-hours market (4:00 p.m. to 8:00 p.m.), which is scheduled to open next month. (Photo: Korea Exchange) According to the financial investment industry and other sources on the 28th, financial authorities and the Korea Exchange are pushing to include exchange-traded products (ETPs) among the instruments excluded from trading in the revised implementation rules for the after-market, which are set to be announced shortly. If the amendments are finalized, trading of all ETPs—including exchange-traded funds (ETFs) and exchange-traded notes (ETNs)—is expected to be completely restricted during the after-hours market. Previously, the Korea Exchange had been accelerating preparations for the introduction of an after-market—scheduled to open on the 14th of next month and operate from 4:00 p.m. to 8:00 p.m.—to meet that deadline. Initially, the Korea Exchange had planned to allow after-market trading of various ETP products, including ETFs. However, it is believed that the exchange proactively withdrew this plan following criticism that single-stock leveraged and inverse ETFs—based on assets such as SamsungElectronics(005930)and SK hynix(000660) —had further exacerbated market volatility amid the recent global semiconductor market correction. Industry observers expect a notice of proposed amendments to the implementing rules to be issued shortly.
“2026 Content Universe Korea” will open on the 16th at the Goyang Flower Exhibition Hall in Ilsan Lake Park, Goyang, Gyeonggi Province. Running through the 17th, the event’s theme is “The Infinitely E…
Pharmaceutical and biotech stocks moved in different directions based on company-specific developments as South Korean stocks fell across both major markets. Daehwa Pharmaceutical gained more than 10%…
“We have completed the delivery of 60 diagnostic devices—part of the initial shipment—to North America and plan to deliver a cumulative total of 130 units by the end of the year.”Kim Han-shin, CEO of …